VRDN
#1924
Viridian Therapeutics, Inc. - Common Stock
18.2 2 USD
0.00%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-0.44%
Variazione Mensile
-17.11%
Variazione di 6 mesi
+19.63%
Variazione Annuale
-18.84%
Chiusura Precedente
18.3 0
Open
18.0 4
Minimo
17.9 6
Massimo
18.3 3
Financials
2020
Current report, 30 Jan 2020
Viridian Therapeutics, Inc. current report, 30 January 2020
8-K
2019
Annual report, FY2019
Viridian Therapeutics, Inc. annual report, FY2019
10-K
Current report, 11 Dec 2019
Viridian Therapeutics, Inc. current report, 11 December 2019
8-K
Current report, 07 Nov 2019
Viridian Therapeutics, Inc. current report, 07 November 2019
8-K
Current report, 31 Oct 2019
Viridian Therapeutics, Inc. current report, 31 October 2019
8-K
Current report, 16 Oct 2019
Viridian Therapeutics, Inc. current report, 16 October 2019
8-K
Quarterly report, Q3 FY2019
Viridian Therapeutics, Inc. quarterly report, Q3 FY2019
10-Q
Current report, 07 Aug 2019
Viridian Therapeutics, Inc. current report, 07 August 2019
8-K
Current report, 19 Jul 2019
Viridian Therapeutics, Inc. current report, 19 July 2019
8-K
Quarterly report, Q2 FY2019
Viridian Therapeutics, Inc. quarterly report, Q2 FY2019
10-Q